Literature DB >> 26944439

Enhanced ADAM17 expression is associated with cardiac remodeling in rats with acute myocardial infarction.

Dong-You Zheng1, Juan Zhao2, Jie-Mei Yang3, Miao Wang4, Xing-Tong Zhang4.   

Abstract

AIM: This study aimed to investigate the dynamic expression of A-disintegrin-and-metalloproteinase-17 (ADAM17) during cardiac remodeling after acute myocardial infarction (AMI). MAIN
METHODS: Forty male Wistar rats with a permanent ligation of the left anterior descending artery were equally divided into four groups based on predefined sacrifice time: MI1d, MI1w, MI4w and MI12w. As controls, 36 rats only with left thoracotomy were equally divided into four groups. Cardiac remodeling was assessed by echocardiography and hematoxylin and eosin (H&E) staining. ADAM17 mRNA was detected by real-time reverse transcription polymerase chain reaction, and protein expression of ADAM17, tissue inhibitor of metalloproteinases-3 (TIMP-3) and TNF-α was analyzed by western blotting. KEY
FINDINGS: The systolic function was sharply worsened in the MI1w group (versus the Con1w group, P<0.05), but left ventricular weight index was significantly increased after 4weeks post-MI (P<0.05). H&E staining revealed that one week after AMI, myocardial tissue in the epicardial border zone of the infarcted heart was mixed with broken mitochondrial cristae and decreased matrix density. ADAM17 mRNA and protein expression was significantly increased, accompanied by decreased TIMP-3 and upregulated TNF-α expression in the MI1w group (versus the MI1d group, all P<0.05). Moreover, dynamic ADAM17 mRNA expression was positively correlated with enlarged LVEDd and LVESd (P=0.001, P=0.003) and negatively with LVEF (P=0.039) in AMI rats. SIGNIFICANCE: Enhanced ADAM17 expression, along with decreased TIMP-3 and increased TNF-α expression, especially within one week after AMI, is associated with cardiac remodeling.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  A disintegrin and metalloproteinase-17; Left ventricle; Myocardial infarction; Myocardial remodeling; Tissue inhibitor of metalloproteinase-3; Tumor necrosis factor-α

Mesh:

Substances:

Year:  2016        PMID: 26944439     DOI: 10.1016/j.lfs.2016.02.097

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Effect of miR-26a-5p targeting ADAM17 gene on apoptosis, inflammatory factors and oxidative stress response of myocardial cells in hypoxic model.

Authors:  Xia Wen; Ying Yin; Xiaohong Li; Tao He; Pengfei Wang; Mingzhe Song; Jiangfeng Gao
Journal:  J Bioenerg Biomembr       Date:  2020-03-13       Impact factor: 2.945

2.  ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.

Authors:  HaiFeng Yang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2022-01-24

Review 3.  Contribution of ADAM17 and related ADAMs in cardiovascular diseases.

Authors:  Tatsuo Kawai; Katherine J Elliott; Rosario Scalia; Satoru Eguchi
Journal:  Cell Mol Life Sci       Date:  2021-02-11       Impact factor: 9.207

4.  Potential role of a disintegrin and metalloproteinase-17 (ADAM17) in age-associated ventricular remodeling of rats.

Authors:  Hainiang Liu; Haoren Wang; Dong Cheng; Qinfu Wang; Zuowei Pei; Ning Zhu; Weiyi Fang; Qin Yu
Journal:  RSC Adv       Date:  2019-05-07       Impact factor: 4.036

Review 5.  A Disintegrin and Metalloprotease 17 in the Cardiovascular and Central Nervous Systems.

Authors:  Jiaxi Xu; Snigdha Mukerjee; Cristiane R A Silva-Alves; Alynne Carvalho-Galvão; Josiane C Cruz; Camille M Balarini; Valdir A Braga; Eric Lazartigues; Maria S França-Silva
Journal:  Front Physiol       Date:  2016-10-18       Impact factor: 4.566

6.  Syzygium Polyanthum Reduced TNF-α and ADAM17 Protein Expression in Myocardial Infarction Rat Model.

Authors:  Refli Hasan; Gontar Alamsyah Siregar; Dharma Lindarto
Journal:  Med Arch       Date:  2020-12

7.  The Downregulation of ADAM17 Exerts Protective Effects against Cardiac Fibrosis by Regulating Endoplasmic Reticulum Stress and Mitophagy.

Authors:  Chang Guan; Hai-Feng Zhang; Ya-Jing Wang; Zhi-Teng Chen; Bing-Qing Deng; Qiong Qiu; Si-Xu Chen; Mao-Xiong Wu; Yang-Xin Chen; Jing-Feng Wang
Journal:  Oxid Med Cell Longev       Date:  2021-05-06       Impact factor: 6.543

Review 8.  Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19.

Authors:  Tomas Rajtik; Peter Galis; Linda Bartosova; Ludovit Paulis; Eva Goncalvesova; Jan Klimas
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

Review 9.  The EGFR-ADAM17 Axis in Chronic Obstructive Pulmonary Disease and Cystic Fibrosis Lung Pathology.

Authors:  Marta Stolarczyk; Bob J Scholte
Journal:  Mediators Inflamm       Date:  2018-01-09       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.